Your browser doesn't support javascript.
loading
Mitochondrial reprogramming induced by CaMKIIδ mediates hypertrophy decompensation.
Westenbrink, B Daan; Ling, Haiyun; Divakaruni, Ajit S; Gray, Charles B B; Zambon, Alexander C; Dalton, Nancy D; Peterson, Kirk L; Gu, Yusu; Matkovich, Scot J; Murphy, Anne N; Miyamoto, Shigeki; Dorn, Gerald W; Heller Brown, Joan.
Afiliação
  • Westenbrink BD; From the Department of Pharmacology (B.D.W., H.L., A.S.D., C.B.B.G., A.C.Z., A.N.M., J.H.B.), Department of Medicine (N.D.D., K.L.P., Y.G.), and Biomedical Sciences Graduate Program (C.B.B.G.), University of California San Diego; School of Internal Medicine, Center for Pharmacogenomics, Washington U
  • Ling H; From the Department of Pharmacology (B.D.W., H.L., A.S.D., C.B.B.G., A.C.Z., A.N.M., J.H.B.), Department of Medicine (N.D.D., K.L.P., Y.G.), and Biomedical Sciences Graduate Program (C.B.B.G.), University of California San Diego; School of Internal Medicine, Center for Pharmacogenomics, Washington U
  • Divakaruni AS; From the Department of Pharmacology (B.D.W., H.L., A.S.D., C.B.B.G., A.C.Z., A.N.M., J.H.B.), Department of Medicine (N.D.D., K.L.P., Y.G.), and Biomedical Sciences Graduate Program (C.B.B.G.), University of California San Diego; School of Internal Medicine, Center for Pharmacogenomics, Washington U
  • Gray CB; From the Department of Pharmacology (B.D.W., H.L., A.S.D., C.B.B.G., A.C.Z., A.N.M., J.H.B.), Department of Medicine (N.D.D., K.L.P., Y.G.), and Biomedical Sciences Graduate Program (C.B.B.G.), University of California San Diego; School of Internal Medicine, Center for Pharmacogenomics, Washington U
  • Zambon AC; From the Department of Pharmacology (B.D.W., H.L., A.S.D., C.B.B.G., A.C.Z., A.N.M., J.H.B.), Department of Medicine (N.D.D., K.L.P., Y.G.), and Biomedical Sciences Graduate Program (C.B.B.G.), University of California San Diego; School of Internal Medicine, Center for Pharmacogenomics, Washington U
  • Dalton ND; From the Department of Pharmacology (B.D.W., H.L., A.S.D., C.B.B.G., A.C.Z., A.N.M., J.H.B.), Department of Medicine (N.D.D., K.L.P., Y.G.), and Biomedical Sciences Graduate Program (C.B.B.G.), University of California San Diego; School of Internal Medicine, Center for Pharmacogenomics, Washington U
  • Peterson KL; From the Department of Pharmacology (B.D.W., H.L., A.S.D., C.B.B.G., A.C.Z., A.N.M., J.H.B.), Department of Medicine (N.D.D., K.L.P., Y.G.), and Biomedical Sciences Graduate Program (C.B.B.G.), University of California San Diego; School of Internal Medicine, Center for Pharmacogenomics, Washington U
  • Gu Y; From the Department of Pharmacology (B.D.W., H.L., A.S.D., C.B.B.G., A.C.Z., A.N.M., J.H.B.), Department of Medicine (N.D.D., K.L.P., Y.G.), and Biomedical Sciences Graduate Program (C.B.B.G.), University of California San Diego; School of Internal Medicine, Center for Pharmacogenomics, Washington U
  • Matkovich SJ; From the Department of Pharmacology (B.D.W., H.L., A.S.D., C.B.B.G., A.C.Z., A.N.M., J.H.B.), Department of Medicine (N.D.D., K.L.P., Y.G.), and Biomedical Sciences Graduate Program (C.B.B.G.), University of California San Diego; School of Internal Medicine, Center for Pharmacogenomics, Washington U
  • Murphy AN; From the Department of Pharmacology (B.D.W., H.L., A.S.D., C.B.B.G., A.C.Z., A.N.M., J.H.B.), Department of Medicine (N.D.D., K.L.P., Y.G.), and Biomedical Sciences Graduate Program (C.B.B.G.), University of California San Diego; School of Internal Medicine, Center for Pharmacogenomics, Washington U
  • Miyamoto S; From the Department of Pharmacology (B.D.W., H.L., A.S.D., C.B.B.G., A.C.Z., A.N.M., J.H.B.), Department of Medicine (N.D.D., K.L.P., Y.G.), and Biomedical Sciences Graduate Program (C.B.B.G.), University of California San Diego; School of Internal Medicine, Center for Pharmacogenomics, Washington U
  • Dorn GW; From the Department of Pharmacology (B.D.W., H.L., A.S.D., C.B.B.G., A.C.Z., A.N.M., J.H.B.), Department of Medicine (N.D.D., K.L.P., Y.G.), and Biomedical Sciences Graduate Program (C.B.B.G.), University of California San Diego; School of Internal Medicine, Center for Pharmacogenomics, Washington U
  • Heller Brown J; From the Department of Pharmacology (B.D.W., H.L., A.S.D., C.B.B.G., A.C.Z., A.N.M., J.H.B.), Department of Medicine (N.D.D., K.L.P., Y.G.), and Biomedical Sciences Graduate Program (C.B.B.G.), University of California San Diego; School of Internal Medicine, Center for Pharmacogenomics, Washington U
Circ Res ; 116(5): e28-39, 2015 Feb 27.
Article em En | MEDLINE | ID: mdl-25605649
RATIONALE: Sustained activation of Gαq transgenic (Gq) signaling during pressure overload causes cardiac hypertrophy that ultimately progresses to dilated cardiomyopathy. The molecular events that drive hypertrophy decompensation are incompletely understood. Ca(2+)/calmodulin-dependent protein kinase II δ (CaMKIIδ) is activated downstream of Gq, and overexpression of Gq and CaMKIIδ recapitulates hypertrophy decompensation. OBJECTIVE: To determine whether CaMKIIδ contributes to hypertrophy decompensation provoked by Gq. METHODS AND RESULTS: Compared with Gq mice, compound Gq/CaMKIIδ knockout mice developed a similar degree of cardiac hypertrophy but exhibited significantly improved left ventricular function, less cardiac fibrosis and cardiomyocyte apoptosis, and fewer ventricular arrhythmias. Markers of oxidative stress were elevated in mitochondria from Gq versus wild-type mice and respiratory rates were lower; these changes in mitochondrial function were restored by CaMKIIδ deletion. Gq-mediated increases in mitochondrial oxidative stress, compromised membrane potential, and cell death were recapitulated in neonatal rat ventricular myocytes infected with constitutively active Gq and attenuated by CaMKII inhibition. Deep RNA sequencing revealed altered expression of 41 mitochondrial genes in Gq hearts, with normalization of ≈40% of these genes by CaMKIIδ deletion. Uncoupling protein 3 was markedly downregulated in Gq or by Gq expression in neonatal rat ventricular myocytes and reversed by CaMKIIδ deletion or inhibition, as was peroxisome proliferator-activated receptor α. The protective effects of CaMKIIδ inhibition on reactive oxygen species generation and cell death were abrogated by knock down of uncoupling protein 3. Conversely, restoration of uncoupling protein 3 expression attenuated reactive oxygen species generation and cell death induced by CaMKIIδ. Our in vivo studies further demonstrated that pressure overload induced decreases in peroxisome proliferator-activated receptor α and uncoupling protein 3, increases in mitochondrial protein oxidation, and hypertrophy decompensation, which were attenuated by CaMKIIδ deletion. CONCLUSIONS: Mitochondrial gene reprogramming induced by CaMKIIδ emerges as an important mechanism contributing to mitotoxicity in decompensating hypertrophy.
Assuntos
Proteína Quinase Tipo 2 Dependente de Cálcio-Calmodulina/fisiologia; Cardiomegalia/enzimologia; Cardiomiopatia Dilatada/etiologia; Insuficiência Cardíaca/etiologia; Mitocôndrias Cardíacas/fisiologia; Acetilcisteína/farmacologia; Animais; Apoptose; Benzilaminas/farmacologia; Proteína Quinase Tipo 2 Dependente de Cálcio-Calmodulina/deficiência; Proteína Quinase Tipo 2 Dependente de Cálcio-Calmodulina/genética; Cardiomegalia/fisiopatologia; Cardiomiopatia Dilatada/fisiopatologia; Cardiomiopatia Dilatada/prevenção & controle; Células Cultivadas; Progressão da Doença; Subunidades alfa Gq-G11 de Proteínas de Ligação ao GTP/deficiência; Subunidades alfa Gq-G11 de Proteínas de Ligação ao GTP/genética; Subunidades alfa Gq-G11 de Proteínas de Ligação ao GTP/fisiologia; Perfilação da Expressão Gênica; Insuficiência Cardíaca/fisiopatologia; Canais Iônicos/biossíntese; Canais Iônicos/genética; Canais Iônicos/fisiologia; Masculino; Camundongos; Camundongos Knockout; Camundongos Transgênicos; Proteínas Mitocondriais/biossíntese; Proteínas Mitocondriais/genética; Proteínas Mitocondriais/fisiologia; Miócitos Cardíacos/metabolismo; Estresse Oxidativo; PPAR alfa/biossíntese; PPAR alfa/genética; Mutação Puntual; Pressão; Interferência de RNA; RNA Mensageiro/biossíntese; RNA Mensageiro/genética; RNA Interferente Pequeno/farmacologia; Ratos; Espécies Reativas de Oxigênio; Análise de Sequência de RNA; Sulfonamidas/farmacologia; Transfecção; Proteína Desacopladora 3
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cardiomiopatia Dilatada / Cardiomegalia / Proteína Quinase Tipo 2 Dependente de Cálcio-Calmodulina / Insuficiência Cardíaca / Mitocôndrias Cardíacas Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cardiomiopatia Dilatada / Cardiomegalia / Proteína Quinase Tipo 2 Dependente de Cálcio-Calmodulina / Insuficiência Cardíaca / Mitocôndrias Cardíacas Idioma: En Ano de publicação: 2015 Tipo de documento: Article